TrumpRx, which lowers U.S. prescription drug prices by cutting pharmacy benefit manager middlemen and applying trade pressure on Europe, will soon compete with a Democratic bill in the Senate HELP Committee.
• The bill, called the Medication Affordability and Patent Integrity Act, requires drug companies to certify consistency between FDA and Patent Office submissions but DOES NOT directly reduce prices.
• But the bill increases sensitive research disclosures across agencies, creating new vulnerabilities for intellectual property theft by Chinese hackers targeting U.S. biotech firms.
🚨The U.S. patent system is why Americans invent most of the world’s new medicines.
This bill weakens it, and for what? … Not a single lower drug price.
🔥This bill should die in committee.